• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在癌症中连接核苷酸生物合成与 DNA 损伤修复/绕过之间的联系。

Connecting dots between nucleotide biosynthesis and DNA lesion repair/bypass in cancer.

机构信息

The Division of Medicinal Chemistry, School of Pharmacy, The University of Connecticut, Storrs, Connecticut 06269, U.S.A.

出版信息

Biosci Rep. 2024 Sep 25;44(9). doi: 10.1042/BSR20231382.

DOI:10.1042/BSR20231382
PMID:39189649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11427732/
Abstract

Purine and pyrimidine nucleotides are crucial building blocks for the survival of cells, and there are layers of pathways to make sure a stable supply of them including de novo nucleotide biosynthesis. Fast-growing cells including cancer cells have high demand for nucleotide, and they highly utilize the nucleotide biosynthesis pathways. Due to the nature of the fast-growing cells, they tend to make more errors in replication compared with the normal cells. Naturally, DNA repair and DNA lesion bypass are heavily employed in cancer cells to ensure fidelity and completion of the replication without stalling. There have been a lot of drugs targeting cancer that mimic the chemical structures of the nucleobase, nucleoside, and nucleotides, and the resistance toward those drugs is a serious problem. Herein, we have reviewed some of the representative nucleotide analog anticancer agents such as 5-fluorouracil, specifically their mechanism of action and resistance is discussed. Also, we have chosen several enzymes in nucleotide biosynthesis, DNA repair, and DNA lesion bypass, and we have discussed the known and potential roles of these enzymes in maintaining genomic fidelity and cancer chemotherapy.

摘要

嘌呤和嘧啶核苷酸是细胞生存的关键构建模块,有许多途径来确保它们的稳定供应,包括从头核苷酸生物合成。包括癌细胞在内的快速生长的细胞对核苷酸的需求很高,它们高度利用核苷酸生物合成途径。由于快速生长细胞的性质,与正常细胞相比,它们在复制过程中更容易出错。自然而然,DNA 修复和 DNA 损伤绕过在癌细胞中被大量利用,以确保复制的保真度和完成,而不会停滞不前。有很多针对癌症的药物模拟核苷酸碱基、核苷和核苷酸的化学结构,这些药物的耐药性是一个严重的问题。在此,我们综述了一些代表性的核苷酸类似物抗癌药物,如 5-氟尿嘧啶,特别讨论了它们的作用机制和耐药性。此外,我们选择了核苷酸生物合成、DNA 修复和 DNA 损伤绕过中的几种酶,并讨论了这些酶在维持基因组保真度和癌症化疗中的已知和潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/e0e7d6d26278/bsr-44-bsr20231382-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/dd259ee3f38e/bsr-44-bsr20231382-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4a409bc26cb9/bsr-44-bsr20231382-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4fdb481e3c32/bsr-44-bsr20231382-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4fca62eefe9d/bsr-44-bsr20231382-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/5e3d95e86de2/bsr-44-bsr20231382-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/e0e7d6d26278/bsr-44-bsr20231382-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/dd259ee3f38e/bsr-44-bsr20231382-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4a409bc26cb9/bsr-44-bsr20231382-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4fdb481e3c32/bsr-44-bsr20231382-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/4fca62eefe9d/bsr-44-bsr20231382-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/5e3d95e86de2/bsr-44-bsr20231382-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e07/11427732/e0e7d6d26278/bsr-44-bsr20231382-g6.jpg

相似文献

1
Connecting dots between nucleotide biosynthesis and DNA lesion repair/bypass in cancer.在癌症中连接核苷酸生物合成与 DNA 损伤修复/绕过之间的联系。
Biosci Rep. 2024 Sep 25;44(9). doi: 10.1042/BSR20231382.
2
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition.5-氟尿嘧啶(5-FU)耐药性与增强抗癌敏感性的新策略:DNA 修复抑制的意义。
Biomed Pharmacother. 2021 May;137:111285. doi: 10.1016/j.biopha.2021.111285. Epub 2021 Jan 20.
3
Lactylation regulated DNA damage repair and cancer cell chemosensitivity.乳酰化作用调节DNA损伤修复及癌细胞的化学敏感性。
Sci Bull (Beijing). 2024 May 15;69(9):1185-1187. doi: 10.1016/j.scib.2024.02.037. Epub 2024 Feb 29.
4
Targeting the DNA damage response and repair in cancer through nucleotide metabolism.通过核苷酸代谢靶向癌症的 DNA 损伤反应和修复。
Mol Oncol. 2022 Nov;16(21):3792-3810. doi: 10.1002/1878-0261.13227. Epub 2022 May 28.
5
A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.一种针对核苷酸切除修复的铂(IV)抗癌前药,以克服顺铂耐药性。
Angew Chem Int Ed Engl. 2016 Dec 12;55(50):15564-15568. doi: 10.1002/anie.201608936. Epub 2016 Oct 13.
6
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment.针对 DNA 损伤反应和修复以提高顺铂类癌症治疗的治疗指数。
Int J Mol Sci. 2021 Jul 30;22(15):8199. doi: 10.3390/ijms22158199.
7
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.在受抗癌药物干扰的胸苷酸合成酶的生化途径内:克服癌症化疗耐药性的新策略。
Drug Resist Updat. 2015 Nov;23:20-54. doi: 10.1016/j.drup.2015.10.003. Epub 2015 Oct 31.
8
DNA polymerase eta and chemotherapeutic agents.DNA 聚合酶 eta 与化疗药物。
Antioxid Redox Signal. 2011 Jun 15;14(12):2521-9. doi: 10.1089/ars.2010.3673. Epub 2011 Mar 18.
9
Exploiting the nucleotide substrate specificity of repair DNA polymerases to develop novel anticancer agents.利用修复 DNA 聚合酶的核苷酸底物特异性开发新型抗癌药物。
Molecules. 2011 Sep 16;16(9):7994-8019. doi: 10.3390/molecules16097994.
10
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis.SHMT2 介导的线粒体丝氨酸代谢通过为核苷酸生物合成提供燃料来驱动 5-FU 耐药性。
Cell Rep. 2022 Aug 16;40(7):111233. doi: 10.1016/j.celrep.2022.111233.

引用本文的文献

1
Comprehensive analysis of a palmitoylation-related prognostic signature in colorectal cancer: Implications for immune therapy and personalized treatment.结直肠癌中棕榈酰化相关预后特征的综合分析:对免疫治疗和个性化治疗的意义
Oncol Lett. 2025 May 16;30(1):350. doi: 10.3892/ol.2025.15096. eCollection 2025 Jul.
2
Vulnerable Nucleotide Pools and Genomic Instability in Yeast Strains with Deletion of the Gene Encoding for Adenylosuccinate Synthetase.腺嘌呤琥珀酸合成酶编码基因缺失的酵母菌株中的易损核苷酸池与基因组不稳定性
Int J Mol Sci. 2025 Apr 8;26(8):3458. doi: 10.3390/ijms26083458.

本文引用的文献

1
Novel insights into the role of translesion synthesis polymerase in DNA incorporation and bypass of 5-fluorouracil in colorectal cancer.新型研究揭示跨损伤合成聚合酶在结直肠癌中 5-氟尿嘧啶的 DNA 掺入和绕过中的作用。
Nucleic Acids Res. 2024 May 8;52(8):4295-4312. doi: 10.1093/nar/gkae102.
2
Arginine-178 is an essential residue for ITPA function.精氨酸 178 是 ITPA 功能所必需的残基。
Arch Biochem Biophys. 2023 Aug;744:109700. doi: 10.1016/j.abb.2023.109700. Epub 2023 Jul 26.
3
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.
癌症化疗及其他:当前状况、候选药物、相关风险以及靶向治疗的进展。
Genes Dis. 2022 Mar 18;10(4):1367-1401. doi: 10.1016/j.gendis.2022.02.007. eCollection 2023 Jul.
4
Vital role of SHMT2 in diverse disease.SHMT2 在多种疾病中的重要作用。
Biochem Biophys Res Commun. 2023 Sep 3;671:160-165. doi: 10.1016/j.bbrc.2023.05.108. Epub 2023 May 26.
5
Novel ITPA variants identified by whole genome sequencing and RNA sequencing.通过全基因组测序和 RNA 测序鉴定新型 ITPA 变异体。
J Hum Genet. 2023 Sep;68(9):649-652. doi: 10.1038/s10038-023-01156-y. Epub 2023 May 29.
6
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies.靶向胃肠道恶性肿瘤治疗的核苷类似物中的先进前药策略。
Front Cell Dev Biol. 2023 Apr 18;11:1173432. doi: 10.3389/fcell.2023.1173432. eCollection 2023.
7
Mutagenic incorporation of inosine into DNA via T:I mismatch formation by human DNA polymerase eta (polη).人类 DNA 聚合酶 η(polη)通过 T:I 错配形成将肌苷诱变掺入 DNA 中。
Biochem J. 2023 May 15;480(9):649-664. doi: 10.1042/BCJ20230029.
8
Inosine triphosphate pyrophosphatase: A guardian of the cellular nucleotide pool and potential mediator of RNA function.肌苷三磷酸焦磷酸酶:细胞核苷酸库的守护者及RNA功能的潜在调节因子。
Wiley Interdiscip Rev RNA. 2023 Sep-Oct;14(5):e1790. doi: 10.1002/wrna.1790. Epub 2023 Apr 24.
9
Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599.地西他滨通过调控 LINC00599 治疗急性髓系白血病的作用机制
Anal Cell Pathol (Amst). 2023 Feb 22;2023:2951519. doi: 10.1155/2023/2951519. eCollection 2023.
10
Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.纳拉滨联合治疗复发或难治性 T 细胞急性淋巴细胞白血病/淋巴瘤。
Blood Adv. 2023 Apr 11;7(7):1092-1102. doi: 10.1182/bloodadvances.2022008280.